Ignite Creation Date:
2024-05-05 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00455026
Status:
COMPLETED
Last Update Posted:
2013-05-30
First Post:
2007-04-01
Brief Title:
Effect of Remifentanil on Electroencephalographic BAR Index During Propofol Anaesthesia
Sponsor:
Melbourne Health
Organization:
Melbourne Health
Study Overview
Official Title:
Effect of Remifentanil on Electroencephalographic BAR Index During Propofol Anaesthesia
Status:
COMPLETED
Status Verified Date:
2007-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Current cortical EEG based depth of anaesthesia monitors do not accurately reflect the effect of opioid drugs We have developed a new theoretically-based method of analysing the EEG Our hypothesis is that this new method will more accurately predict depth of anaesthesia than the Bispectral Index BIS monitor in patients having elective surgery
Detailed Description:
Patients aged 18-60 years presenting for elective surgery under general anaesthesia will be recruited They will be randomised to receive remifentanil effect-site target 0 2 or 4 ngml Then anaesthesia will be induced with propofol Loss of the eyelash reflex response to command and response to electrical stimulation will be measured The raw EEG will be recorded and analysed off-line using our new method and also for BIS values Anaesthesia will then proceed according to the needs of the patient and the surgery
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None